Drew Named Full Professor at Campbell University

     Dr. Richard H. Drew has been promoted to full professor by Campbell University’s School of Pharmacy. Drew is an infectious diseases clinical pharmacist at Duke University Medical Center, professor of pharmacy at Campbell University, and assistant research professor in the School of Medicine at Duke University.
     He received a bachelor’s degree in pharmacy at the University of Rhode Island and Master of Science and Doctor of Pharmacy degrees from the University of North Carolina at Chapel Hill. He completed a residency in Hospital Pharmacy Practice at Duke University Medical Center. Drew is board-certified as a pharmacotherapy specialist with added qualifications in infectious diseases pharmacotherapy.
     He maintains an active clinical practice in the areas of adult internal medicine and infectious diseases and currently serves as co-director to postgraduate education programs for pharmacists in the area of infectious diseases at Duke University Medical Center. He has held leadership roles in professional organizations such as the Infectious Diseases Practice Research Network of the American College of Clinical Pharmacists (chairman), the Triangle College of Clinical Pharmacy (president) and North Carolina Association of Pharmacists (Pharmacotherapy Special Interest Group chairman). Drew also holds active membership in the American Association of Colleges of Pharmacy, North Carolina Infectious Diseases Society, American Society of Microbiology, and the Society of Infectious Diseases Pharmacists. He currently serves on numerous professional and academic committees.
     In addition, Drew has authored and/or coauthored numerous publications, including research papers and book chapters and presented at several national and international meetings on the topic of infectious diseases pharmacotherapy. His practice and research interests include antimicrobial utilization, information technology, respiratory tract infections, Gram-positive infections, and invasive fungal infections in the compromised host. He currently serves as a scientific reviewer for “Pharmacotherapy,” “Annals of Pharmacotherapy,” “Clinical Infectious Diseases,” “Antimicrobial Agents and Chemotherapy,” “American Journal of Transplantation,” and “Up To Date.”

Bulletin 0065-3/15/05